全文获取类型
收费全文 | 152028篇 |
免费 | 12357篇 |
国内免费 | 5799篇 |
专业分类
耳鼻咽喉 | 567篇 |
儿科学 | 3425篇 |
妇产科学 | 794篇 |
基础医学 | 10084篇 |
口腔科学 | 718篇 |
临床医学 | 19416篇 |
内科学 | 20495篇 |
皮肤病学 | 531篇 |
神经病学 | 9331篇 |
特种医学 | 7456篇 |
外国民族医学 | 97篇 |
外科学 | 20354篇 |
综合类 | 30157篇 |
一般理论 | 1篇 |
预防医学 | 7801篇 |
眼科学 | 1130篇 |
药学 | 14894篇 |
114篇 | |
中国医学 | 7366篇 |
肿瘤学 | 15453篇 |
出版年
2024年 | 162篇 |
2023年 | 2445篇 |
2022年 | 3871篇 |
2021年 | 6509篇 |
2020年 | 6381篇 |
2019年 | 4776篇 |
2018年 | 4666篇 |
2017年 | 5761篇 |
2016年 | 5938篇 |
2015年 | 5897篇 |
2014年 | 11173篇 |
2013年 | 11703篇 |
2012年 | 10157篇 |
2011年 | 10765篇 |
2010年 | 8669篇 |
2009年 | 8016篇 |
2008年 | 7848篇 |
2007年 | 8011篇 |
2006年 | 7375篇 |
2005年 | 6385篇 |
2004年 | 5061篇 |
2003年 | 4367篇 |
2002年 | 3546篇 |
2001年 | 3203篇 |
2000年 | 2600篇 |
1999年 | 2075篇 |
1998年 | 1682篇 |
1997年 | 1583篇 |
1996年 | 1313篇 |
1995年 | 1169篇 |
1994年 | 1039篇 |
1993年 | 783篇 |
1992年 | 738篇 |
1991年 | 612篇 |
1990年 | 561篇 |
1989年 | 466篇 |
1988年 | 408篇 |
1987年 | 345篇 |
1986年 | 307篇 |
1985年 | 351篇 |
1984年 | 268篇 |
1983年 | 164篇 |
1982年 | 201篇 |
1981年 | 183篇 |
1980年 | 177篇 |
1979年 | 126篇 |
1978年 | 84篇 |
1977年 | 77篇 |
1976年 | 53篇 |
1975年 | 46篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
《The Journal of thoracic and cardiovascular surgery》2023,165(1):301-326
ObjectiveThe use of mechanical circulatory support (MCS) in lung transplantation has been steadily increasing over the prior decade, with evolving strategies for incorporating support in the preoperative, intraoperative, and postoperative settings. There is significant practice variability in the use of these techniques, however, and relatively limited data to help establish institutional protocols. The objective of the AATS Clinical Practice Standards Committee (CPSC) expert panel was to review the existing literature and establish recommendations about the use of MCS before, during, and after lung transplantation.MethodsThe AATS CPSC assembled an expert panel of 16 lung transplantation physicians who developed a consensus document of recommendations. The panel was broken into subgroups focused on preoperative, intraoperative, and postoperative support, and each subgroup performed a focused literature review. These subgroups formulated recommendation statements for each subtopic, which were evaluated by the entire group. The statements were then developed via discussion among the panel and refined until consensus was achieved on each statement.ResultsThe expert panel achieved consensus on 36 recommendations for how and when to use MCS in lung transplantation. These recommendations included the use of veno-venous extracorporeal membrane oxygenation (ECMO) as a bridging strategy in the preoperative setting, a preference for central veno-arterial ECMO over traditional cardiopulmonary bypass during the transplantation procedure, and the benefit of supporting selected patients with MCS postoperatively.ConclusionsAchieving optimal results in lung transplantation requires the use of a wide range of strategies. MCS provides an important mechanism for helping these critically ill patients through the peritransplantation period. Despite the complex nature of the decision making process in the treatment of these patients, the expert panel was able to achieve consensus on 36 recommendations. These recommendations should provide guidance for professionals involved in the care of end-stage lung disease patients considered for transplantation. 相似文献
2.
3.
4.
5.
6.
7.
《Transfusion and apheresis science》2022,61(1):103366
ObjectiveThere is a paucity of data concerning the use of granulocyte colony-stimulating factors (G-CSFs) in pediatric patients with acute lymphoblastic leukemia (ALL). The aim of the present study was to evaluate the effect of G-CSF use on relapse-free and overall survival in 358 consecutive, newly diagnosed pediatric ALL patients uniformly treated at the same institution between April 2012 and April 2020.Materials and MethodsPatients were evaluated in two separate periods, based on the G-CSF treatment approach. All patients who underwent ALL treatment between April 2012 and December 2016 received G-CSF (G-CSF+ arm; n: 245) in the course of the protocol for reducing the risk of febrile neutropenia and/or inducing neutrophil recovery to prevent any treatment delay. No patients after December 2016 received G-CSF, even if they belonged to the high-risk group, and these were included in the G-CSF? arm (n: 113).ResultsEstimated mean relapse-free (106.5 months; 95 % CI 102?110.8 vs 82 months 95 % CI 75.2?88.9; p: 0.794) and overall survival (111.4 months; 95 % CI 108?114.8 vs 85 months 95 % CI 80.4?89.8; p: 0.431) rates were similar between the G-CSF+ and G-CSF? groups.ConclusionsOur findings indicate that G-CSF use during ALL treatment had no effect on relapse rates or overall survival. 相似文献
8.
9.
目的 通过分析特发性肺纤维化急性加重期(AE-IPF)患者证候与血清生物标志物的关系,为中医辨证治疗提供参考。方法 采用观察性研究设计,收集2019年3月至2019年11月三个中心的AE-IPF患者76例,其中痰热壅肺证26例、痰浊阻肺证50例,并纳入健康志愿者10例作为对照。采用ELISA测定患者血清CCL18、HMGB1、KL-6、MMP-7、SP-A和SP-D水平,分析与中医证候的相关性。结果 AE-IPF患者血清CCL18、HMGB1、KL-6、MMP-7、SP-A和SP-D水平均显著高于健康对照组。血清CCL18、HMGB1、KL-6、MMP-7和SP-D水平在痰热壅肺证和痰浊阻肺证患者间无显著性差异(P>0.05),而血清SP-A水平存在显著性差异(P<0.05)。结论 血清SP-A与AE-IPF证候存在一定的相关性,血清SP-A的浓度升高,与痰热壅肺证关系越密切,反之,血清SP-A浓度降低,则与痰浊阻肺证关系越密切。AE-IPF痰热壅肺证患者的预后可能较痰浊阻肺证患者更差。 相似文献
10.
目的:探索嘌呤能受体X1(purinergic receptor,P2RX1)与肺腺癌(LUAD)患者预后及免疫细胞浸润的相关性。方法:利用生物信息学技术分析非小细胞肺癌中P2RX1的表达及其甲基化与患者预后的关系,对P2RX1共表达基因进行富集分析并筛选核心基因。利用TIMER 2.0数据库、R软件等分析P2RX1与免疫细胞、免疫检查点、免疫基质评分等的相关性。结果:P2RX1在LUAD中表达下调,低表达P2RX1的患者预后较差(P<0.05),且P2RX1与肿瘤纯度、分期等临床病理因素有关(P<0.05)。P2RX1的表达与肺鳞癌患者预后无明显相关。Cg06475633等P2RX1 CpG位点甲基化与患者预后相关。P2RX1共表达基因主要富集于免疫细胞活化、分化等通路和生物学进程,核心基因主要包括BTK、IKZF1等。P2RX1的表达与B细胞浸润、免疫/基质评分、PD-1、CTLA-4等多个免疫检查点显著相关(P<0.05)。结论:P2RX1有望成为LUAD诊断和免疫治疗的新靶点。 相似文献